CRANBURY, N.J.--Physicians’ Education Resource® (PER®), the leading resource for oncology and hematology continuing medical education (CME), will host the Miami Breast Cancer Conference®: Attendee Tumor Board at 2 p.m., Oct. 27, announced Phil Talamo, president, PER®.
“As one of the largest and most impactful breast cancer meetings in the world, we are excited for this new educational opportunity for our loyal attendees. They will be able to log in and present their own cases in real time and they will hear the experts discuss and provide their perspectives in a virtual video environment,” said Talamo.
Miami Breast Cancer Conference®: Attendee Tumor Board webcast, is an educational extension to the annual Miami Breast Cancer Conference®, which will discuss the latest in breast cancer research, controversies and other breakthroughs. The webcast is designed to provide medical professionals the newest information on clinical trials, novel agents and evolving treatment strategies, and emerging data. The livestream will feature the following expert faculty from renowned health care institutions:
-
Patrick I. Borgen, M.D., chair, department of surgery, Maimonides Medical Center
-
Elizabeth A. Mittendorf, M.D., Ph.D., associate professor, department of breast surgical oncology, The University of Texas MD Anderson Cancer Center.
-
Debu Tripathy, M.D., professor and chair department of breast medical oncology, The University of Texas MD Anderson Cancer Center
For registration and more information, visit Gotoper.com/go/mbcc18atb
About PER®:
Since 1995, PER® has been the leading provider of live, online and print CME activities focusing on oncology and hematology by providing high-quality, evidence-based activities featuring leading experts who focus on the application of practice-changing advances. In 2017, PER® will develop and implement 21 historic annual legacy conferences in the Unites States and Europe, along with many world-renowned online learning formats. PER® is also the publisher of the monthly peer-reviewed American Journal of Hematology/Oncology®, is accredited by the Accreditation Council for Continuing Medical Education and California Board of Registered Nurses. PER®, and is part of the Cranbury, New Jersey-based Michael J. Hennessy Associates, Inc. family of businesses. Learn more at http://www.gotoper.com and http://www.mjhassoc.com.
